ACRS

3.4401.71%
JL

James Loerop

Chief Business Officer

Mr. James Loerop, also known as Jim, serves as Chief Business Officer at Aclaris Therapeutics, Inc. since January 31, 2022. He had been Executive Vice President of Business Development and Strategic Planning of Anika Therapeutics, Inc. since July 8, 2019 until January 27, 2022. Mr. Loerop served as Chief Corporate Development Officer at Lupin Limited since September 2017 till July 2019 and was its President. Mr. Loerop was responsible to lead Lupin's overall corporate development efforts and is also responsible for its global M&A and business development functions. He integrates Lupin's Business development, Licensing and M&A teams to drive the company's global M&A and Business Development strategy. He is a seasoned professional has experience in the pharmaceutical industry. He began his career as a Sales Representative with Solvay Pharmaceuticals. He served as Senior Vice President of Global Business Development at Alexion Pharmaceuticals from April 2015 to September 2017, GlaxoSmithKline as Vice President of North America Business Development from September 2010 to April 2015. He served as Senior Vice President of Corporate Development at Stiefel Laboratories Inc. since May 2006. Mr. Loerop was responsible for identifying, negotiating and implementing commercially viable new business opportunities, acquisitions and divestitures. He also developed strategic Partnerships and new business affairs that deliver innovation in the form of products, alliances, new technology or services. He has a thorough background in the industry. He served at Solvay Pharmaceuticals, GlaxoSmithKline, KV Pharmaceutical, Curatek Pharmaceuticals and IMS Health. Mr. Loerop served as Vice President of Corporate Development and Business Expansion at KV Pharmaceutical Co. in St. Louis, Mo. He holds a Bachelor of Science in Marketing from Western Michigan University.

Positions